ロード中...
2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model
BACKGROUND: Norovirus can cause chronic infections with serious morbidity and mortality in immunocompromised patients. While there are no FDA-approved medications for these infections, nitazoxanide, ribavirin, and enterally administered pooled immunoglobulin (IVIG) are used off-label on the basis of...
保存先:
| 出版年: | Open Forum Infect Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6809658/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.2328 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|